Oligonucleotide-based strategies to reduce gene expression

被引:35
|
作者
Dagle, JM
Weeks, DL [1 ]
机构
[1] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA
基金
美国国家卫生研究院;
关键词
oligonucleotides; antisense; triplex;
D O I
10.1046/j.1432-0436.2001.690201.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Research on embryonic development and differentiation provides a sensitive, but challenging opportunity to use a variety of techniques designed to modulate gene expression. Changes in the expression of a single gene can alter levels of other genes and provide information on developmentally regulated gene expression pathways. The morphological consequences of altered gene expression can link gene expression to developmental fate. Oligonucleotide-based approaches offer a variety of means to potentially disrupt normal gene expression. The basis for some of these approaches is presented in this review.
引用
收藏
页码:75 / 82
页数:8
相关论文
共 50 条
  • [21] Oligonucleotide-Based Therapies for Renal Diseases
    Carton-Garcia, Fernando
    Saande, Cassondra Jeanette
    Meraviglia-Crivelli, Daniel
    Aldabe, Rafael
    Pastor, Fernando
    BIOMEDICINES, 2021, 9 (03)
  • [22] Oligonucleotide-based telomerase inhibitors with a photoresponsive α-chloroaldehyde
    Kobata, Kentaro
    Matsubara, Kazuki
    Nishikawa, Risa
    Narita, Yuki
    Matsuo, Kazuya
    Waku, Tomonori
    Kobori, Akio
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2025, 120
  • [23] Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease
    Sardone, Valentina
    Zhou, Haiyan
    Muntoni, Francesco
    Ferlini, Alessandra
    Falzarano, Maria Sofia
    MOLECULES, 2017, 22 (04):
  • [24] Oligonucleotide-Based Tools for Studying Zebrafish Development
    Shestopalov, Ilya A.
    Chen, James K.
    ZEBRAFISH, 2010, 7 (01) : 31 - 40
  • [25] Delivery of oligonucleotide-based therapeutics: challenges and opportunities
    Hammond, Suzan M.
    Aartsma-Rus, Annemieke
    Alves, Sandra
    Borgos, Sven E.
    Buijsen, Ronald A. M.
    Collin, Rob W. J.
    Covello, Giuseppina
    Denti, Michela A.
    Desviat, Lourdes R.
    Echevarria, Lucia
    Foged, Camilla
    Gaina, Gisela
    Garanto, Alejandro
    Goyenvalle, Aurelie T.
    Guzowska, Magdalena
    Holodnuka, Irina
    Jones, David R.
    Krause, Sabine
    Lehto, Taavi
    Montolio, Marisol
    Van Roon-Mom, Willeke
    Arechavala-Gomeza, Virginia
    EMBO MOLECULAR MEDICINE, 2021, 13 (04)
  • [26] OLIGONUCLEOTIDE-BASED CORRECTION OF CF SPLICING MUTATIONS
    Dang, Y. L.
    van Heusden, C.
    O'Kelly-Nickerson, V
    Randell, S.
    Boucher, R.
    Juliano, R.
    Kreda, S. M.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S201 - S201
  • [27] Current Status of Oligonucleotide-Based Protein Degraders
    Shih, Po-Chang
    Naganuma, Miyako
    Demizu, Yosuke
    Naito, Mikihiko
    PHARMACEUTICS, 2023, 15 (03)
  • [28] Oligonucleotide-Based Therapies for Inflammatory Bowel Disease
    Bevivino, Gerolamo
    Sedda, Silvia
    Marafini, Irene
    Monteleone, Giovanni
    BIODRUGS, 2018, 32 (04) : 331 - 338
  • [29] Oligonucleotide-Based Therapies for Inflammatory Bowel Disease
    Gerolamo Bevivino
    Silvia Sedda
    Irene Marafini
    Giovanni Monteleone
    BioDrugs, 2018, 32 : 331 - 338
  • [30] Antisense Oligonucleotide-Based Therapy of Viral Infections
    Tarn, Woan-Yuh
    Cheng, Yun
    Ko, Shih-Han
    Huang, Li-Min
    PHARMACEUTICS, 2021, 13 (12)